Strategic Objectives

Our main objective is to grow our revenue and market share in the IT services market in Denmark and the life sciences IT services market internationally, while maintaining or improving our operating profit margins.

We intend to accomplish the principal objective by continuing to focus on the following key elements of the strategy:

  • Continue to improve customer satisfaction
  • Continue to expand our market share in Denmark and support Danish customers’ internationalization
  • Leverage our strong expertise in life sciences internationally
  • Continue to enhance and deepen our expertise and service offerings through specialization and standardization
  • Maintain focus on operational excellence
  • Maintain our culture and enhance our human capital

Our business model combined with our global delivery centers and scale-driven operating leverage has secured robust operating profit margins over the past decade. At the same time, the increasing diversification of our customer base and the long-term nature of many of our major contracts add to business transparency, mitigate operational risk and warrant long-lasting customer relationships.

A trusted provider of regulated IT for life sciences

As a highly specialized IT services provider to life sciences, NNIT is dedicated to supporting international life science companies in optimizing their businesses, reducing cost and complying with regulatory requirements. Currently serving the life sciences market in Western Europe, North America and China, NNIT’s main activities are advisory services and projects, with an increasing focus on application and infrastructure outsourcing.

Based on NNIT’s profound insights and industry experience within life sciences, we are able to create value through IT solutions and expertise while operating IT according to GxP (Good x Practice) pharma industry standards.

Regulation remains a key concern and business driver in life sciences, and NNIT continually monitors the regulatory environment in order to offer the necessary IT support. This includes clinical data warehouse, serialization requirements and ISO IDMP (International Organization for Standardization(ISO) for the identification of medicinal products(IDMP)), and changes to existing requirements from the FDA, the US Food and Drug Administration, and the EMA, the European Medicines Agency.

The preferred IT outsourcing partner for customers of Danish origin

As a preferred IT outsourcing partner for customers of Danish origin, we are able to support our clients during their internationalization. Essentially, we follow our clients wherever they go. NNIT is currently the third-largest IT services vendor in the Danish market, with a 2016 total market share of 7% according to IDC. According to Gartner, the market is forecasted to grow at a compound annual growth rate (CAGR) of 3.4% in the period 2015-2020. In the past decade NNIT has continuously demonstrated organic revenue growth rates above the market average, and will continue to pursue profitable growth and increased market share going forward.

Investor relations contact

Klaus Hosbond Skovrup
Head of Investor Relations

+45 3079 5355

Email alerts

To subscribe to receive updates by email.


Follow NNIT